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Abstract
Objectives The diagnosis of acute pyelonephritis (APN) re-
quires demonstration of parenchymal involvement. When
no predisposing conditions are found, non-complicated
APN is suspected and CT or MRI should be performed.
Diffusion-weighted (DW) MRI might be useful, quicker
and cheaper than the standard gadolinium-enhanced (GE)
MRI. The aim of this study is to compare DW-MRI with
GE-MRI to test its diagnostic accuracy in APN.
Methods Of 318 consecutive patients hospitalised for APN,
279 underwent MRI. Four hundred and fourteen MR studies
(first test and follow-up examinations) were gathered and
data were processed using Diffusion Analysis software.
DW-MRI has been compared with GE-MRI for evaluating
diagnostic agreement.
Results Two hundred and forty-four patients were diag-
nosed as having APN; 35 were negative. One hundred and
sixty-three APN cases were considered non-complicated
and selected for the study. Among the 414 MR examinations,
comparing DW-MRI with GE-MRI, positive correlation was
found in 258 cases, negative in 133. There were 14 false-
negatives and 9 false-positives. DW-MRI achieved sensitivity
95.2 %, specificity 94.9 %, positive predictive value 96.9 %,
negative predictive value 92.3 % and accuracy 94.6 %.
Conclusions DW-MRI is reliable for diagnosing non-
complicated APN. The high diagnostic agreement between
DW-MRI and GE-MRI offers new perspectives in diagnos-
tic management, enabling diagnosis of non-complicated
APN without using ionising radiation or contrast media.
Key Points
• The diagnosis of acute pyelonephritis (APN) requires
demonstration of renal involvement.
• Hitherto magnetic resonance imaging required gadolini-
um enhancement (GE-MRI) to establish this diagnosis.
• But diagnostic agreement between diffusion-weighted and
GE-MRI offers new diagnostic opportunities.
• Quantification of ADC values can help diagnose and
monitor APN.
• DW-MRI avoids ionising radiation and paramagnetic
contrast medium administration.
Keywords Acute pyelonephritis . Urinary tract infections .
Gadolinium-enhanced magnetic resonance imaging .
Diffusion-weighted magnetic resonance imaging . Apparent
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Introduction
In the USA acute pyelonephritis (APN) has an incidence as
high as 250,000 cases per year, mostly in young women, and
necessitates 200,000 hospitalisations every year [1–3]. There
are very few data on the overall incidence of APN in Europe,
being influenced by the type of sanitary system and the
hospitalisation policy; however, based on a previous
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surveillance on the referral area of our university hospital, the
gross incidence of hospitalised APN cases can be estimated as
about 26.5 new cases per year per 100,000 inhabitants.
APN develops when uropathogens ascend to the kidneys
from faecal flora; rarely it is caused by seeding of the
kidneys by bacteraemia.
According to the British Medical Research Council
Bacteriuria Committee [4], the definition of APN is clinical,
based on a classic tetrad of high fever, costovertebral angle
tenderness, signs or symptoms of lower urinary tract infection
(UTI) (leucocytosis, pyuria) and positive urinary cultures. As
this definition does not discriminate between upper UTI with
or without renal parenchymal involvement, other authors fol-
low a “pathological” criterion, based upon the demonstration
of kidney involvement by imaging techniques [5].
A general consensus is reached for the definition of “com-
plicated” versus “non-complicated”APN [6–8]. “Complicated”
refers to the presence of systemic (any factor affecting the
immune response, including diabetes, collagen disease, neopla-
sia, chemotherapy, HIV positivity, neuromuscular disease,
haemoglobinopathies) or anatomical (any factor causing ob-
struction, including active stone disease, prostatic hypertrophy,
kidney malformations, reflux nephropathy, polycystic kidney
disease and indwelling catheters) predisposing factors. “Non-
complicated” refers to their absence.
Moreover the most significant elements in the recent liter-
ature regarding APN are the revised guidelines for treatment.
In their paper Gupta et al. [9] underline the need for differen-
tiating between patients requiring hospitalisation and those
who do not. Only imaging data can distinguish between upper
UTI with and without parenchymal involvement.
In view of its low sensitivity for the presence of paren-
chymal lesions [10] and the high sensitivity for obstructive
lesions, conventional ultrasound is used to identify the pres-
ence of anatomical predisposing factors.
In cases in which there is a clinical suspicion of APN, in
which no predisposing condition is found at ultrasound, non-
complicated APN should be suspected and a second-line im-
aging test has to be performed. Computed tomography (CT) or
magnetic resonance imaging (MRI) examination allows pre-
cise definition of the inflammatory areas and evidence of
abscesses [11–13]. As patients with non-complicated APN
are mostly women of childbearing age, MR might be chosen
as the preferred imaging technique and CT should be
performed only in the case of contraindications or logistical
problems (long wait before the availability of an MRI) [14].
MRI, using a parallel imaging technique acquisition, is
able to perform dynamic enhanced studies, with diagnostic
accuracy superimposable onto CT [15]. It does not use
ionising radiation and it is equipped with considerable con-
trast resolution. Between sequences performed in a basal
setting, diffusion-weighted magnetic resonance imaging
(DW-MRI) has recently gained particular interest [16]. It is
realisable by analysing the spin dephasing and signal loss
caused by random motion along magnetic field gradients.
The apparent diffusion coefficient (ADC), as a quantitative
parameter calculated from the DW-MRI, combines the ef-
fects of capillary perfusion and water diffusion in the intra-
cellular extravascular space.
The kidneys are very challenging organs for DW-MRI.
The development of echo-planar imaging (EPI), high gradi-
ent amplitudes, multichannel coils and parallel imaging
have been helpful in increasing the applications of DW
sequences. In particular, the introduction of parallel imag-
ing, such as sensitivity encoding (SENSE), which allowed
reduction in the echo-train length (TE) and the K-space
filling time, led to considerably less motion artefacts at
image acquisition, thus enabling high-quality DW images
of the body to be acquired. Hence, DWI might be useful in
differentiating APN, with the advantage of lower costs and
execution times than gadolinium-enhanced MRI (GE-MRI).
The aim of our study was to evaluate diagnostic agree-
ment between DWI and GE-MRI (the “gold standard” test),
to estimate the capability of DW-MRI in the evaluation of
non-complicated APN and to demonstrate its potential reli-
ability in the diagnostic pathway.
Materials and methods
Selection of patients
All consecutive patients admitted to our hospital with the
diagnosis of APN in the period January 2007-September
2009, and hospitalised from the Emergency Department
(ED) to the Emergency Medicine, Urology and Nephrology
or Internal Medicine wards, were considered for the study. All
patients were referred to the Radiology Unit during
hospitalisation and were followed at least until clinical and
radiological healing (with a 3- to 6-week interval, according to
the severity of the disease). Clinical data were gathered pro-
spectively, whereas the MRI studies have been analysed
retrospectively.
The clinical suspicion of APN was made by the ED
physicians, based on the presence of at least one of the
three main symptoms (fever, costovertebral angle ten-
derness or pain, recent or present UTI) and at least one
sign of systemic infection (high white blood cells or C-
reactive protein [CRP]). The diagnosis of present or
recent UTI was based on urinalysis or the clinical
history. All patients with a clinical picture suggestive
of APN underwent abdominal ultrasound, whenever
possible in the ED, and were hospitalised. In patients
hospitalised for fever of unknown origin, in which the
diagnosis was made during hospitalisation, ultrasound
was performed subsequently.
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The following general data were collected, to differentiate
complicated versus non-complicated APN: age, sex, previous
UTI, previous history of pyelonephritis, previous stone disease.
Patients with kidney stones were not included. At referral, the
following clinical data were collected: fever, costovertebral
angle-tenderness, lower UTI symptoms, other symptoms; anti-
biotic therapy within the last 72 h; other therapies.
Laboratory data were obtained using standard laboratory
methods. The following data, obtained in the ED at
hospitalisation, were considered: serum creatinine, blood
cell counts, CRP, urinary cultures, haemocultures and the
results of dipstick urinalysis were also recorded when avail-
able. In the presence of systemic predisposing factors and/or
of anatomical predisposing factors detected by ultrasound,
the APN was considered as complicated and the patients
were not included in the study.
By definition, diagnosis was made by a second-line im-
aging technique. MRI was performed in 279 patients (264
females and 15 males) with a median age of 35 years (16–
77 years). Thirty-nine remaining patients (including two
pregnant patients) did not undergo MRI at our Unit or were
subjected to CT or, rarely, underwent only ultrasound.
Selection of patients to submit for MRI at our Service was
usually carried out by our nephrologists.
Out of 279 patients who underwent MRI, diagnosis of
APN was made in 244, while in 35 cases the investigation
was negative.
In keeping with the diagnosis of non-complicated APN,
all patients (163) were female, with a median age of 32 years
but a wide age range (16–72 years), with a normal genito-
urinary tract.
Eighty-one patients with complicated APN, diagnosed on
the basis of gender (15 male patients with benign prostatic
hypertrophy), systemic (diabetes, collagen diseases, immune-
haematological disorders, neoplasia, neuromuscular disease
or surgical sequelae) or anatomical (pyelo-ureteral joint de-
fect) predisposing factors (46 patients), or parenchymal se-
quelae of previous pyelonephritis (e.g. contracted small-sized
kidney due to vesico-ureteral reflux) or renal stones disease
(20 patients) were not included in the study.
Complicated APN were excluded to avoid confounding
causes in detecting parenchymal inflammatory damage (e.g.
an increased pressure in the urinary tract in the obstructive
uropathy might alter parenchymal perfusion and conse-
quently either enhancement or diffusion of water
molecules).
One of the patients included had a congenital solitary
kidney.
Imaging techniques
The diagnosis of pyelonephritis was made by GE-MRI as a
second-line imaging technique, used as a gold standard test.
MRI was performed using a 1.5-T system (ACHIEVA,
Philips Medical System, The Netherlands) with a maximum
gradient strength of 30 mT/m, a slew rate of 150 mT
m−1 ms−1 and a four-channel phased-array coil. As a rule,
imaging data were obtained within 48 h of hospitalisation.
Before acquisition of DW-MRI sequences, we performed
in each patient a morphological study of the kidneys.
The following protocol was used.
Basal MRI test
& Survey BFFE (balanced fast field echo) sequences along
the three orthogonal axes (x, y and z)
& Sequence with function of locator, performed in maxi-
mum inspiratory and expiratory breath-hold
& Axial TSE SENSE (turbo spin echo sSSH T2-weighted
sequences) (TR=375 ms; double TE=100 ms, Sp
7.0/1.0, turbo factor 47; EPI factor 1, NSA 1, SENSE
body coil)
& Axial SPAIR SENSE Sat-SPIR (spectral attenuation in-
version recovery) sequences (TR=418 ms; TE=80 ms,
Sp 7.0/1.0, turbo factor 47; EPI factor 1, NSA 1, SENSE
body coil)
& Axial DWI—TRIG SENSE Sat-SPIR sequences (TR=
910 ms; TE=d0.0 72 ms, Sp 7.0/1.0 mm, turbo factor
65; EPI factor 65, NSA 4, matrix 190/256; SENSE body
coil; b 0-100-700 triggered with imaging time 1.40 min)
& Axial DWI—SENSE Sat-SPIR sequences (TR=1,275–
2,572 ms; TE=d0.0 62–65 ms, Sp 7.0/1.0 mm, turbo
factor 62–65; EPI factor 62–65, NSA 4, matrix 190/256;
SENSE body coil; b 0 and b 600 with breath-hold and
imaging time 20–25 s)
DW MR images with slice thickness of 7 mm and inter-
val of 1 mm were obtained in the axial plane during breath-
hold (30 s) by using a single-shot spin-echo EPI (SE EPI)
sequence, with three b values (0 and 600 s/mm2). The
gradients were applied along the three orthogonal axes (x,
y and z) and subsequently averaged to minimise the effects
of diffusion anisotropy. The single-shot SE EPI sequence
was performed using a parallel imaging technique acquisi-
tion (SENSE), which allows a faster acquisition for breath-
hold technique and avoids magnetic susceptibility artefacts.
Fat saturation was used to prevent chemical shift artefacts,
and two presaturation slabs were positioned perpendicular
to the anterior and posterior sections, respectively, to sup-
press motion influences.
& d-ADC maps were then calculated for the different
“weightings”: b=0–600 and b=0–100–700. The ADC
value was calculated. The mean of the ADC values
derived from the regions of interest (ROI=15 mm2,
about 15 pixels) was then calculated in the axial plane.
Image analysis was performed off-line at a Windows
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workstation (Dell, Xeon CPU 3.20 GHz) with dedicated
software (Extended MR WorkSpace 2.6.3.1 2009;
Philips Medical Systems, The Netherlands)
& Axial basal WAVE FSAT SENSE (water selective vol-
ume excitation) WATS 2D with fat suppression se-
quences (TR=9.7 ms; TE=4.9 ms; Sp 7.0/3.5 mm, turbo
factor 1; EPI factor 1, NSA 1, matrix 128/224; SENSE
body coil)
Circular ROIs with a diameter of approximately 1 cm
were manually placed in kidney for the measurement of
ADC values in the healthy tissue, in the pathological renal
parenchyma and in the focal renal lesions. Measurement of
the mean ± SD of the ADC values was obtained by three
circular ROIs in the mid-kidney at the level of the cortico-
medullary junction. For each ROI the average ADC values
(ADCavg) were calculated. ADCs of the kidneys were cal-
culated separately for the low (ADClow b=0 s/mm
2) and
high (ADChigh b=300 or 700 s/mm
2) b values to allow
differentiation of the relative influence of the perfusion
fraction and true diffusion. Data were processed using
Diffusion Analysis software (Extended MR WorkSpace
2.6.3.1 2009).
GE-MRI study
Study after bolus intravenous administration of contrast
agent (Gadobutrol, 1 mmol/kg), 2 ml/s:
& Coronal 2D bolus-track sequences (TR=4.0 ms, TE=
0.9 ms, Sp 80/0.0 mm, turbo factor 1; EPI factor 1, NSA
1, matrix 128/224; SENSE body coil) in the course of
administration of contrast medium with an injector to
determine dynamic sequences (care-bolus)
& Coronal Angio-RM 3D RES sequences SENSE, high
resolution (TR=5.1 ms, TE=1.5 ms, Sp 3.0/-1.5 mm,
turbo factor 1; EPI factor 1; SENSE body coil). After
about 20–30 s (cortical-arterial phase). The beginning of
MR data acquisition is determined by the vision of the
initial opacification of the abdominal aorta using a care-
bolus
& Axial dynamic 3D T1-weighted DYN THRIVE (T1
high-resolution isotropic volume examination)
sequences—SAT SPIR (fat suppression) (TR=4.0 ms,
TE=1.9 ms, turbo factor 60; EPI factor 1, NSA 1, matrix
135/240; SENSE body coil). In the course of adminis-
tration of contrast medium at 60–80 s (nephrographic
phase) and 100–120 s (nephrographic/early excretory
phase)
& Axial mdc WAVE FSAT sequences SENSE (water se-
lective volume excitation) WATS 2D with fat suppres-
sion (TR=9.7 ms, TE=4.9 ms, Sp 7.0/3.5 mm, turbo
factor 1; EPI factor 1, NSA 1, matrix 128/224; SENSE
body coil). In late pyelographic phase at 5 min
Analysis of results
When analysing the MRI data, the diagnosis of APN re-
quires demonstration of the following:
& Changes in renal volume (kidney enlargement, presum-
ably due to oedema from active infection)
& Alteration of cortico-medullary delineation (reduced or
absent)
& Focal or diffuse parenchymal signal alteration, in the
basal test
& After the administration of contrast medium (GE study),
on T1-weighted sequences reduction of parenchymal
contrast enhancement in the affected area (single or
multiple lesions, unilateral or bilateral); presence and
size of parenchymal focal lesions; abscessed areas, as
fluid lesions delineated by a peripheral halo
& Dilation of the collecting system (mild, moderate,
marked)
& Perinephric inflammatory fluid and stranding of the
perinephric fat
& Hyperintensity on DW sequences with high b value and
hypointensity in the same area on ADC maps, correlat-
ing with focal reduction of enhancement at T1-weighted
sequences in the GE study (Fig. 1)
Morphological evaluation of the images was performed
in consensus by two experienced radiologists who were
blinded to the DW-MR images and data. Cortico-
medullary delineation and focal or diffuse parenchymal
signal alterations, presence and size of parenchymal lesions,
dilation of the collecting system and perirenal changes were
mainly observed and annotated.
GE-MRI study was finally compared with the DW se-
quences to evaluate diagnostic agreement, the former being
considered the gold standard test.
Considering APN lesions as hyperintense areas due to re-
duction of water diffusion, sensitivity, specificity, positive and
negative predictive value, and overall accuracy of DWI were
calculated. Correlation between ADC in normal parenchyma
and in pyelonephritic lesions was also statistically analysed.
Results
We recorded 318 patients hospitalised from January 2007 to
September 2009 with a clinical diagnosis of APN at ED
admission based on the presence of flank pain, fever and
leucocytosis or elevated CRP.
MRI was performed in 279 patients (264 female).
Morphological examination with GE-MRI was diagnostic
in 244 subjects, with evidence of single or multiple areas of
parenchymal hypointensity. Thirty-five patients were nega-
tive at the GE-MRI examination.
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We included in our study and retrospectively analysed
163 patients with imaging-confirmed diagnosis of non-
complicated APN, submitted for both GE-MRI and DW
sequences. In keeping with this setting, all patients were
female, with a median age of 32 years (16–72 years) and a
normal genito-urinary tract.
Four hundred and fourteen MRI examinations were
performed, including the first test and the subsequent control
investigations (1–4 studies per patient, mean 2.1). GE-MRI
was used as a gold standard and confirmed APN in 272
repeated acquisitions (reduced perfusion with enhancement
gaps). Among positive studies, DW sequences had a positive
result in 258 and a negative result in 14. A radiological con-
firmation of APN by DW-MRI (parenchymal hyperintensity
signal in high b images) was obtained in 267 studies (Fig. 1).
Dealing with functional DW-MRI, the mean ADC value
was 2.38±0.14×10−3 mm2 s−1, with a range of 1.99–2.76×
10−3 mm2 s−1. In subjects who underwent repeated MRI, the
ADC values were highly reproducible.
Total or sectorial kidney swelling was detected in
121 out of 172 affected kidneys (70.3 %). The severity
of the lesion was not uniform. The cortico-medullary
gradient was reduced or absent in 18 patients. In 163
patients with onset APN, basal study revealed abnor-
malities in signal intensity in the foci of inflammation
in 65 cases, characterised by a picture of isointensity on
T1-weighted sequences and slight hyperintensity on T2-
weighted images.
After bolus intravenous administration of contrast agent,
about 94.5 % of the patients (154 cases) had lesions in only
one kidney. Lesions were bilateral in nine patients (5.5 %),
but they were multiple in 128 cases (78,5 %). Overall, 621
lesions were detected, with an average of 3.8 injuries per
pathological kidney. Simple non-abscessed lesions only
were present in 100 patients, while at least one abscessed
lesion was present in 63 patients (38.5 %; Fig. 2) and only 2
had perirenal collections. A thin layer of perirenal effusion
was recognised in 104 cases of parenchymal inflammation.
Fig. 1 Acute pyelonephritic
lesion in the right kidney. Axial
T1-DYN T1 high-resolution
isotropic volume examination
(THRIVE) imaging after
administration of contrast
medium in the early (a) and
nephrographic phase (b):
heterogeneous defect of
contrast enhancement with
delimitation of cortical
microabscesses (arrow). c On
axial diffusion-weighted
imaging sensitivity encoding
(SENSE) with b=700 s/mm2,
the lesion appears markedly
hyperintense. Qualitative
apparent diffusion coefficient
(ADC) map from diffusion-
weighted (DW) echo-planar
MR images demonstrates
hypointense signal (d). The
quantitative sampling in the
lesion (e) and at the level of the
middle third of the contralateral
parenchyma (f) shows
significantly lower ADC values
in inflammatory parenchymal
foci compared with healthy
tissue
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Considering all 414 MR studies, comparing DWI study
with GE-MRI used as a gold standard, positive correlation
was found in 258 cases (true-positive) and negative correla-
tion in 133 (true-negative). In 14 tests GE acquisitions were
positive, while DW sequences were negative (false-negative;
Fig. 3). Restriction of the diffusivity of water molecules with
slightly hyperintense signal has been highlighted, compared
with negative contrast medium enhancement, in nine investi-
gations (false-positive; Fig. 4; Table 1).
Overall DW-MRI versus GE-MRI achieved sensitivity
95.2 %, specificity 94.9 %, positive predictive value (PPV)
96.9 %, negative predictive value (NPV) 92.3 % and diag-
nostic accuracy (DA) 94.6 % (Table 2).
For a quantitative evaluation, 150 samples of the attenua-
tion coefficient were eventually conducted on the ADC map
on parenchymal foci, which always resulted in hypointensity
on the map with greyscale; as many comparison samples were
collected in areas of healthy ipsilateral parenchyma and in
unaffected kidney. In areas of affected parenchyma ADC
value in mm2/s was found to be consistently lower (mean
1.385; minimum 1.109, maximum 1.717; absolute deviation
compared with the average 0.150, standard deviation 0.124)
compared with healthy parenchyma (mean 2.383; minimum
1.989, maximum 2.763; absolute deviation compared with the
average 0.226, standard deviation 0.140), with P value<
0.0001 (Fig. 5).
Discussion
APN is a topic that has remained relatively neglected in
terms of imaging research and its diagnosis is still a
challenge. None of the clinical signs or laboratory bio-
chemical markers at presentation allows discrimination
between a few small lesions and multifocal or abscessed
ones [13]. Thus, imaging techniques are needed to
assess the severity of kidney involvement and to plan
the antibiotic therapy.
Diagnostic imaging plays a role in looking for previous
occult structural or functional abnormalities that may re-
quire intervention, to assess those patients at significant risk
of more life-threatening complications as in diabetic, elderly
or immunosuppressed patients, to balance the severity of the
infection and to evaluate the extent of organ damage subse-
quent to a resolved acute infection.
Second-line imaging tests (CT or MRI) should be sys-
tematically used to define the presence, extent and type of
parenchymal lesions, and to reveal complications (such as
abscess or perirenal fluid collections), in order to tailor in-
terventions to the specific clinical contexts [17, 18].
Our interest in APN originated from the observation of
the increasing frequency of this disease and from the uncer-
tain indications in the literature with regard to the opportu-
nity to perform DW-MRI [19–23].
Hence, since 2007 we have been collecting data of pa-
tients admitted to the ED with a clinical suspicion of APN
according to our setting, in order to study the results in non-
complicated APN patients routinely hospitalised and under-
going an extensive imaging work-up (ultrasound and either
MRI or CT). Our study focused on DW-MRI as an imaging
tool for the diagnosis of APN along with treatment and
follow-up of patients, also to test the alternatives to our
imaging-guided diagnostic and therapeutic approach.
The latest studies have already shown the prospective
value of DW-MRI in the assessment of various renal dis-
eases, such as renal ischaemia, pyonephrosis and diffuse
renal disease [19–23]. On the contrary, there is no evidence
of its role in the diagnosis and follow-up of the APN and no
data are available regarding the diagnostic accuracy in
adults. Studies conducted in animal models [24] with histo-
logical confirmation reported sensitivity and specificity of
GE-MRI in the diagnosis of experimentally induced APN,
Fig. 2 Severe acute pyelonephritis (APN) with inflammatory paren-
chymal foci and multiple abscesses. a Post-contrast axial T1 water
selective volume excitation (WAVE) imaging: the right kidney is
swollen and has perfusion defects related to inflammatory parenchymal
foci. b DWI spin echo (SE) echo-planar image (EPI) with b=700 s/
mm2: lesions appear heterogeneously hyperintense, with small areas of
greater intensity due to abscesses. c The ADC map shows hypointense
signal in correspondence of the same lesions
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respectively, of 91 % and 93 %. Other studies in children,
performed in comparison with 99mTc-DMSA scintigraphy,
show that the GE-MRI, using inversion-recovery sequences,
has overlapping sensitivity (90.9 %) and specificity
(88.8 %) in the diagnosis of APN, but they underline its
superiority in differentiating scars from inflammatory foci in
the early stages of disease [25].
Gradient echo MRI has a semeiotics and diagnostic ac-
curacy at least comparable to that of CT in the evaluation of
morphological and functional impairment in renal inflam-
mation and its complications [26]. Some downsides, how-
ever, must be noted. The test is relatively time-consuming
(about 20–25 min), with inevitable consequences in the
management of the flow of scheduled patients. It also pre-
sents high costs and, even if to a lesser extent than iodinated
contrast medium, the administration of gadolinium chelates
is not recommended in patients with allergic anamnesis.
Eventually, studies in recent years on systemic fibrosis due
to gadolinium contraindicate its use in patients with renal
impairment [27, 28].
In our centre, the study protocol of APN with MRI also
implies the use, at baseline, of the DW sequences, with rapid
execution. In the literature several investigators suggest the
use of DW-MRI in extraneurological fields [29, 30]. In the
nephro-urological setting, data of great interest are available
in the study of kidney disease, such as chronic impairment
or infections [19–22, 31], dealing with the characterisation
of focal lesions [32–34], in the definition of renal function
[23] and follow-up in the renal transplant setting [35].
Recently, Taouli et al. [36] and Kim et al. [37] were the first
to compare DW-MRI with GE-MRI, emphasising the value
of DW sequences, able not only to add valuable diagnostic
information but also to be considered a valid alternative to
contrastographic investigation in the characterisation of fo-
cal renal lesions.
As shown by the results of our study, comparing the
diagnostic accuracy of DW sequence with contrast-
enhanced MRI, DW-MRI clearly has high sensitivity, spec-
ificity, positive/negative predictive value and diagnostic ac-
curacy, all close to 95 %.
The evaluation of the data detected a very small number
of false-positives (FP) and false-negatives (FN), moreover
based on images of very small extension and found in tests
carried out in the monitoring phase. In particular, FN were
represented by areas of irregular parenchymal contrast me-
dium enhancement and absence of signal abnormalities on
DW-MRI. In these cases there might be the onset of inflam-
matory foci on a background of parenchymal scarring due to
previous infection: once the acute injury resolved, it remains
a contrast enhancement caused by pre-existing parenchymal
distortion. Another explanation for these events could be
that the inflammatory lesions had been already improved
when the patients were submitted for radiological examina-
tion or that they were so mild as to be undetectable. The FP,
in turn, corresponded to focal parenchymal hyperintensity
on DW-MRI without correlated enhancement after adminis-
tration of gadolinium. This framework, as well as being
secondary to artefacts, dealing with the extreme sensitivity
of the DW-MRI to movement, can be related to the phe-
nomenon of persistence of the T2 signal, even with high b
values, referred to as “T2 shine-through”, which occurs in
Fig. 3 False-negative DWI study. a Small APN lesion in the middle
third of the right kidney visible on T1 WAVE sequences after admin-
istration of contrast medium in the late nephrographic phase (arrow) as
an heterogeneous perfusion defect. b On DWI sequences the lesion
shows no signs of restriction of diffusivity.
Fig. 4 False-positive DWI study. a On axial DWI SENSE with b=
700 s/mm2 there was a small parenchymal area of restricted diffusion,
without enhancement after administration of contrast medium in the
T1-WAVE sequence (b)
Table 1 Diffusion weighted imaging (DWI) results compared with
GE-MRI results
DW-MRI + DW-MRI -
GE-MRI + 258 14 272
GE-MRI − 9 133 142
267 147 414
Table 2 Diagnostic performance of DW-MRI versus GE-MRI
Sensitivity 95.2 %
Specificity 94.9 %
Positive predictive value 96.9 %
Negative predictive value 92.3 %
Diagnostic accuracy 94.6 %
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tissues where there is a free diffusion of water molecules.
This finding, presumably detectable in the presence of small
residual collections or microcysts, leads to mistakes in the
qualitative assessment of DW images, which require verifi-
cation with the study of the ADC map. Finally, it may be
assumed that the weakly hyperintense signal only detectable
on DW-MRI may be related to persistent moderate inflam-
matory events of such magnitude as to go undetected by
contrast enhanced testing, assuming the more sensitive eval-
uation by DW-MRI. The phenomenon, which occurred in-
variably in subsequent controls in areas where in the acute
phase there was a more marked inflammatory process, may
suggest that the gold standard tends to underestimate the
process and that DW-MRI allows a greater “conspicuity”
than contrast-enhanced examination. This finding, which to
our knowledge does not find any other description in the
literature and that is probably secondary to minor compres-
sive alterations due to a residual component of oedematous
swelling, together with slight irregularities in the tissue
microperfusion (so-called “pseudodiffusion”), should find
histological confirmation, but this is not feasible in an
abnormality without surgical implications. However, in clin-
ical practice, in case of persistent positivity of DW-MRI
after the negativity of the clinical setting and the completion
of the programmed therapy, the finding must be considered
not relevant and the patient recovered.
Because of the inflammatory parenchymal damage re-
sponsible for interstitial space reduction, with a resulting
decrease in the diffusivity of water molecules, the quantita-
tive evaluation of the ADC map is of considerable impor-
tance. It is based on the study of the ADC of water mole-
cules, always associated with qualitative analysis of the DW
signal, to avoid mistakes related to the influence of T2
weighting of the sequence. In selected subjects with a proper
clinical laboratory grading, it was interesting to note how
the inflammatory disease could be identified not only on the
basis of the hyperintense signal on DW-MRI, with high b
factor and with hypointensity on the ADC map, but also as a
result of a calculation of the attenuation coefficient after
ROI positioning, with the lowest result compared with that
obtained on areas of healthy parenchyma at the
corticomedullary junction [38]. The results derived from
estimates, especially for lesions of limited dimensions, still
encounter uncertainties because of the choice of the “b”
factor, for the inter-operator variability in measuring with
ROI ADC values of some specific areas, as well as on the
possible differences between the magnets (either from dif-
ferent manufacturers or because of different field strengths
of devices of the same company) [38, 39]. This aspect is a
significant problem that has not been solved; indeed, several
authors using different b values have not come to superim-
posable results [40]. In agreement with data reported by
Macarini et al. [38], with reduced acquisition times, the
value of the “b” factor of approximately 600–700 used in
our study can be considered an acceptable compromise
between image quality, affected by a high “b”, which re-
duces the signal-to-noise ratio (SNR), and a weighting of the
“real” diffusion that is more faithful and true with these
values. As recommended by Fukuda et al. [41], the ROI
cursors were placed at the level of the middle third of the
kidney in correspondence with the cortico-medullary junc-
tion, as the evaluation of ADC values in the central portion
of the kidneys is less influenced by the perfusion effect.
With such a procedure it is more reliable to make a compar-
ison with data derived from the positioning of the ROI in
inflammatory parenchymal foci [21].
Different studies [23, 31, 32, 38, 42] have calculated the
intrinsic proton diffusion in the abdominal organs and, in
particular, in the kidneys. In the literature the normal
reported values range from 1.60 to 2.65×10−3 mm2 s−1,
probably in relation to the breadth of the diffusion gradient
used (500–1,300 s/mm2). According to data in the literature,
in our study the mean value of renal parenchyma in healthy
subjects was 2.40±0.20×10−3 mm2 s−1. Comparing our
study on APN with other results, Thoeny et al. [21] studied
a population of healthy volunteers and patients with various
Fig. 5 Mean (± SD) of the
ADC map values in a sample of
150 lesions, measured in the
APN foci (column A) and in the
contralateral healthy
corresponding parenchyma
(column B). The difference
between the two values
(1.385±0.124 vs 2.383±0.140)
was extremely significant
(P<0.0001)
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parenchymal diseases; in the APN patients they found ADC
values of entities significantly lower than in healthy contra-
lateral parenchyma, showing one of the few reports where
reference is made precisely to inflammatory renal parenchy-
mal disease and in which the results have been very similar
to ours.
In conclusion, according to our study results, DW-MRI
of the kidney seems to be a feasible, rapid and reliable
method as quantification of ADC values can be useful in
diagnosing non-complicated APN. The high diagnostic
agreement we have found between GE-MRI and DW-MRI
offers new perspectives in diagnostic management, enabling
monitoring of APN in a short time without use of ionising
radiation or administration of paramagnetic contrast medi-
um. We can assume the use of DW-MRI, together with the
performance of the usual basal sequences T1 and T2, in the
acute phase, possibly in the ED, affecting minimally (negli-
gible time is required) the workflow of the MRI service,
thus allowing a timely therapeutic approach. The subsequent
checks, performed about every 3 weeks until complete res-
olution of the inflammatory process, may instead be
programmed with DWI alone.
In addition, DW-MRI is an alternative to dynamic inves-
tigation in all cases where there are contraindications to
administration of iodinated and/or paramagnetic contrast
medium, such as those patients with renal insufficiency
and pregnant or lactating women. Eventually, the short
duration of the examination and the easy response and
reproducibility of ADC values allow a proper diagnostic
evaluation even in uncooperative subjects or slightly sedat-
ed claustrophobic ones.
Dealing with costs too, DW-MRI is an interesting tool for
detecting non-complicated APN, thanks to its inherent cost
and its potential impact on the suitability and timeliness of
treatment.
References
1. Hooton TM, Stamm WE (1997) Diagnosis and treatment of un-
complicated urinary tract infection. Infect Dis Clin North Am
11:551–581
2. Georgi A, Reddy YNV, Gautam G (2012) Diagnosis of acute
pyelonephritis with recent trends in management. Nephrol Dial
Transplant 27:3391–3394
3. Ramakrishnan K, Schedi DC (2005) Diagnosis and manage-
ment of acute pyelonephritis in adults. Am Fam Physician
71:933–942
4. Medical Research Council Bacteriuria Committee (1979)
Recommended terminology of urinary tract infection: a report by
the members of Medical Research Council Bacteriuria Committee.
Br Med J 2:717–719
5. Talner LB, Davidson AJ, Lebowitz RL, Dalla Palma L, Goldman
SM (1994) Acute pyelonephritis: can we agree on terminology?
Radiology 192:297–305
6. Dyer RB (1997) CT of renal inflammatory disease. Invited com-
mentary. Radiographics 17:867–868
7. Soulen MC, Fishman EK, Goldman SM, Gatewood OM (1989)
Sequelae of acute renal infection: CT evaluation. Radiology
173:423–426
8. Webb JAW (1987) The role of imaging in adult acute urinary tract
infection. Eur Radiol 7:837–843
9. Gupta K, Hooton TM, Naber KG et al (2011) International clinical
practice guidelines for the treatment of acute uncomplicated cysti-
tis and pyelonephritis in women: a 2010 update by the Infectious
Diseases Society of America and the European Society for
Microbiology and Infectious Diseases. Clin Infect Dis 52:103–120
10. Parenti GC, Passari A (2001) Pielonefrite acuta: ruolo della
diagnostica per immagini. Radiol Med 101:251–254
11. Craig WD, Brent JW, Travis MD (2008) From the archives of the
AFIP, pyelonephritis: radiologic-pathologic review. Radiographics
28:255–276
12. Majd M, Nussbaum Blask AR, Markle BM et al (2001) Acute
pyelonephritis: comparison of diagnosis with 99mTc-DMSA,
SPECT, spiral CT, MR imaging, and power Doppler US in an
experimental pig model. Radiology 218:101–108
13. Piccoli GB, Consiglio V, Deagostini MC et al (2011) The clinical
and imaging presentation of acute “non complicated” pyelonephri-
tis, a new profile for an ancient disease. BMC Nephrol 12:68–78
14. Martina MC, Campanino PP, Caraffo F et al (2010) Dynamic
magnetic resonance imaging in acute pyelonephritis. Radiol Med
115:287–300
15. Nikken JJ, Krestin GP (2007) MRI of the Kidney: state of the art.
Eur Radiol 17:2780–2793
16. Hagmann P, Jonasson L, Maeder P, Thiran JP, Wedeen VJ, Meuli R
(2006) Understanding diffusion MR imaging technique.
Radiographics 26:S205–S223
17. Kawashima A, Sandler CM, Goldman SM (2000) Imaging in acute
renal infection. BJU Int 86:70–79
18. Johansen TE (2004) The role of imaging in urinary tract infections.
World J Urol 22:392–398
19. Muller MF, Prasad PV, Bimmler D, Kaiser A, Edelman RR (1994)
Functional imaging of the kidney by means of measurement of the
apparent diffusion coefficient. Radiology 193:711–715
20. Chow LC, Bammer R, Moseley ME, Sommer FG (2003) Single
breath-hold diffusion-weighted imaging of the abdomen. J Magn
Reson Imaging 18:377–382
21. Thoeny HC, De Keyzer F, Oyen RH, Peeters RR (2005) Diffusion-
weighted MR imaging of kidneys in healthy volunteers and pa-
tients with parenchymal diseases: initial experience. Radiology
235:911–917
22. Xu Y, Wang X, Jiang X (2007) Relationship between the renal
apparent diffusion coefficient and glomerular filtration rate: pre-
liminary experience. J Magn Reson Imaging 26:678–681
23. Carbone SF, Gaggioli E, Ricci V, Mazzei F, Mazzei MA, Volterrani
L (2007) Diffusion-weighted magnetic resonance imaging in the
evaluation of renal function: a preliminary study. Radiol Med
112:1201–1210
24. Pennigton DJ, Lonergan GJ, Flack CE, Waguespeck RL, Jackson
CB (1996) Experimental pyelonephritis in piglets: diagnosis with
MR imaging. Radiology 201:199–205
25. Kovanlikaya A, Okkay N, Cakmakci H, Ozdoðan O, Degirmenci
B, Kavukcu S (2004) Comparison of MRI and renal cortical
scintigraphy findings in childhood acute pyelonephritis: prelimi-
nary experience. Eur J Radiol 49:76–80
26. Israel GM (2006) MRI of the kidney and urinary tract. J Magn
Reson Imaging 24:725–734
27. SIRM-SIN-AINR (2007) Fibrosi nefrogenica sistemica.
Raccomandazioni per l’uso degli agenti di contrasto a base di
Gadolinio. http://www.sirm.org e www.sin-italy.org. Accessed
30.10.2007
Eur Radiol (2013) 23:3077–3086 3085
28. Sadowski EA, Bennett LD, Chan MR et al (2007) Nephrogenic
systemic fibrosis: risk factors and incidence estimation. Radiology
243:148–157
29. Arlinghaus LR, Li X, Levy M et al (2010) Current and future
trends in magnetic resonance imaging assessments of the response
of breast tumors to neoadjuvant chemotherapy. J Oncol 2010
30. Eccles CL, Haider EA, Haider MA, Fung S, Lockwood G, Dawson
LA (2009) Change in diffusion weighted MRI during liver cancer
radiotherapy: preliminary observations. Acta Oncol 48:1034–1043
31. Namimoto T, Yamashita Y, Mitsuzaki K, Nakayama Y, Tang Y,
Takahashi M (1999) Measurement of the apparent diffusion coef-
ficient in diffuse renal disease by diffusion weighted echo-planar
MR imaging. J Magn Reson Imaging 9:832–837
32. Cova M, Squillaci E, Stacul F et al (2004) Diffusion-weighted
MRI in the evaluation of renal lesions: preliminary results. Br J
Radiol 77:851–857
33. Squillaci E, Manenti G, Di Stefano F, Miano R, Strigari L,
Simonetti G (2004) Diffusion-weighted MR imaging in the evalu-
ation of renal tumours. J Exp Clin Cancer Res 23:39–45
34. Zhang J, Tehrani YM, Wang L, Ishill NM, Schwartz LH, Hricak H
(2008) Renal masses: characterization with diffusion-weighted
MR imaging-a preliminary experience. Radiology 247:458–464
35. Palmucci S, Mauro LA, Veroux P et al (2011) Magnetic resonance
with diffusion-weighted imaging in the evaluation of transplanted
kidneys: preliminary findings. Transplant Proc 43:960–966
36. Taouli B, Thakur R, Mannelli L et al (2009) Renal lesions: char-
acterization with diffusion-weighted imaging versus contrast-
enhanced MR imaging. Radiology 251:398–407
37. Kim S, Jain M, Harris AB et al (2009) T1 Hyperintense renal
lesions: characterization with diffusion weighted MR imaging
versus contrast-enhanced MR imaging. Radiology 251:796–807
38. Macarini L, Stoppino LP, Milillo P, Ciuffreda P, Fortunato F, Vinci
R (2010) Diffusion-weighted MRI with parallel imaging tech-
nique: apparent diffusion coefficient determination in normal kid-
neys and in non malignant renal diseases. Clin Imaging 34:432–
440
39. Colagrande S, Belli G, Politi LS, Mannelli L, Pasquinelli F, Villari
N (2008) The influence of diffusion and relaxation-related factors
on signal intensity: an introductive guide to magnetic resonance
diffusion-weighted imaging studies. J Comput Assist Tomogr
32:463–474
40. Colagrande S, Carbone SF, Carusi LM, Cova M, Villari N (2006)
Magnetic resonance diffusion-weighted imaging:
extraneurological applications. Radiol Med 111:392–419
41. Fukuda Y, Ohashi I, Hanafusa K et al (2000) Anisotropic diffusion
in kidney: apparent diffusion coefficient measurements for clinical
use. J Magn Reson Imaging 11:156–160
42. Mürtz P, Flacke S, Träber F, Van den Brink JS, Gieseke J, Schild
HH (2002) Abdomen: diffusion-weighted MR imaging with pulse-
triggered single-shot sequences. Radiology 224:258–264
3086 Eur Radiol (2013) 23:3077–3086
Copyright of European Radiology is the property of Springer Science & Business Media B.V.
and its content may not be copied or emailed to multiple sites or posted to a listserv without
the copyright holder's express written permission. However, users may print, download, or
email articles for individual use.
